The prophylaxis of hereditary angioedema attacks with recombinant human C1 inhibitor: who will take advantage of the individualized treatment approach? [electronic resource]
Producer: 20140508Description: 1207-9 p. digitalISSN:- 1398-9995
No physical items for this record
Publication Type: Letter; Research Support, Non-U.S. Gov't; Comment
There are no comments on this title.
Log in to your account to post a comment.